Vikram Lamba

Vikram Lamba


Vikram Lamba joined Fortuna in 2016 and brings over 20 years of global experience in building healthcare companies from concept to execution.

From 2011 to 2016, Mr. Lamba served as Chief Executive Officer of Zosano Pharma Corporation and as a member of its Board of Directors. Before that, he served as Chief Financial Officer and Chief Business Officer of Predictive Biosciences, Inc. from July 2008 until he joined Zosano in 2011. Prior to that, Mr. Lamba served as Vice President of Corporate Development at Advanced Medical Optics, Inc. (acquired by Abbott), where he was responsible for many significant merger and acquisition transactions and strategic alliances, and as Vice President for Finance and Chief Financial Officer of GeneOhm Sciences, Inc. (acquired by Becton Dickinson).

In all, Mr. Lamba has executed 25+ career deals worth more than $7 billion and managed post-merger integration for most acquisitions. Mr. Lamba also has over 16 years of global experience in various positions with Burmah Castrol PLC and Bayer AG. During his eight years with Bayer in Canada, Germany and the U.S., Mr. Lamba held positions in areas of general management, mergers and acquisitions and finance, including turning around a $200MM loss making division at Bayer manufacturing rFVIII to annual profitability in excess of $250MM by successful cost containment and manufacturing efficiencies.

Mr. Lamba received his M.B.A. from the Asian Institute of Management and spent his final year as an exchange student at The Wharton School of the University of Pennsylvania.